Department of Medicine, Division of Endocrinology, University of Arizona College of Medicine, Tucson.
Arterioscler Thromb Vasc Biol. 2021 Feb;41(2):734-754. doi: 10.1161/ATVBAHA.120.314655. Epub 2020 Dec 10.
NFU1 is a mitochondrial iron-sulfur scaffold protein, involved in iron-sulfur assembly and transfer to complex II and LAS (lipoic acid synthase). Patients with the point mutation NFU1 and CRISPR/CAS9 (clustered regularly interspaced short palindromic repeats/clustered regularly interspaced short palindromic repeat-associated 9)-generated rats develop mitochondrial dysfunction leading to pulmonary arterial hypertension. However, the mechanistic understanding of pulmonary vascular proliferation due to a single mutation in NFU1 remains unresolved. Approach and Results: Quantitative proteomics of isolated mitochondria showed the entire phenotypic transformation of NFU1 rats with a disturbed mitochondrial proteomic landscape, involving significant changes in the expression of 208 mitochondrial proteins. The NFU1 mutation deranged the expression pattern of electron transport proteins, resulting in a significant decrease in mitochondrial respiration. Reduced reliance on mitochondrial respiration amplified glycolysis in pulmonary artery smooth muscle cell (PASMC) and activated GPD (glycerol-3-phosphate dehydrogenase), linking glycolysis to oxidative phosphorylation and lipid metabolism. Decreased PDH (pyruvate dehydrogenase) activity due to the lipoic acid shortage is compensated by increased fatty acid metabolism and oxidation. PASMC became dependent on extracellular fatty acid sources due to upregulated transporters such as CD36 (cluster of differentiation 36) and CPT (carnitine palmitoyltransferase)-1. Finally, the NFU1 mutation produced a dysregulated antioxidant system in the mitochondria, leading to increased reactive oxygen species levels. PASMC from NFU1 rats showed apoptosis resistance, increased anaplerosis, and attained a highly proliferative phenotype. Attenuation of mitochondrial reactive oxygen species by mitochondrial-targeted antioxidant significantly decreased PASMC proliferation.
The alteration in iron-sulfur metabolism completely transforms the proteomic landscape of the mitochondria, leading toward metabolic plasticity and redistribution of energy sources to the acquisition of a proliferative phenotype by the PASMC.
NFU1 是一种线粒体铁硫支架蛋白,参与铁硫组装和向复合物 II 和 LAS(硫辛酸合酶)的转移。具有 NFU1 点突变和 CRISPR/CAS9(成簇规律间隔短回文重复/成簇规律间隔短回文重复相关 9)产生的大鼠的患者会出现线粒体功能障碍,导致肺动脉高压。然而,由于 NFU1 中的单个突变导致肺血管增殖的机制理解仍未解决。方法和结果:分离线粒体的定量蛋白质组学显示,NFU1 大鼠的整个表型发生了转变,线粒体蛋白质组景观受到干扰,涉及 208 种线粒体蛋白的表达发生显著变化。NFU1 突变扰乱了电子传递蛋白的表达模式,导致线粒体呼吸显著下降。肺动脉平滑肌细胞(PASMC)中糖酵解对线粒体呼吸的依赖增加,激活了 GPD(甘油-3-磷酸脱氢酶),将糖酵解与氧化磷酸化和脂质代谢联系起来,从而放大了糖酵解。由于脂酰基辅酶 A 短缺导致 PDH(丙酮酸脱氢酶)活性降低,脂肪酸代谢和氧化增加得到补偿。由于上调了 CD36(分化群 36)和 CPT(肉毒碱棕榈酰转移酶)-1 等转运蛋白,PASMC 变得依赖于细胞外脂肪酸来源。最终,NFU1 突变导致线粒体中抗氧化系统失调,导致活性氧水平增加。NFU1 大鼠的 PASMC 表现出抗凋亡、增强的回补作用,并获得高度增殖的表型。线粒体靶向抗氧化剂显著降低 PASMC 增殖,减少线粒体活性氧。结论:铁硫代谢的改变完全改变了线粒体的蛋白质组景观,导致 PASMC 的代谢可塑性和能量来源的重新分配,从而获得增殖表型。